The Honorable Alex Azar II, JD, sits on several corporate and advisory boards, is an Adjunct Professor of Business at the University of Miami Herbert Business School, and is a member of the Board of Trustees of the Aspen Institute and the Healthcare Leadership Council, the Health and Medicine Division Committee of the National Academies of Sciences, Engineering, and Medicine, and advisory boards of the Stanford University School of Medicine Department of Health Policy, the American Task Force On Lebanon, the Bipartisan Policy Center’s Future of Health Care Group, and the National Institute for Healthcare Management Foundation. Secretary Azar served as the 24th Secretary of the U.S. Department of Health and Human Services (2018-2021), leading over 85,000 employees with a budget of over $1.4 trillion. He was the architect of Operation Warp Speed, delivering COVID-19 vaccines and therapeutics in record time. He led the historic transformation of the healthcare system in the United States and HHS’s response to the unprecedented COVID-19 pandemic. He previously served as president of Lilly USA, LLC, the largest affiliate of global biopharmaceutical leader Eli Lilly and Company. Before his tenure at Lilly, Azar was the Deputy Secretary of HHS and its General Counsel.